Tuesday, December 31, 2013

Planmeca MAKES STRATEGIC INVESTMENT IN E4D TECHNOLOGIES




Helsinki, Finland, December 23, 2013 – Planmeca, the world’s largest privately owned dental imaging company and equipment manufacturer, announced today that it has made a non-controlling, strategic investment in E4D Technologies, LLC, developer of the E4D CAD/CAM Restorative System.  This strategic investment reinforces Planmeca’s on-going commitment to help dental providers improve patient care by offering a comprehensive portfolio of integrated digital dental solutions for dentists and dental laboratories.

Planmeca will co-develop CAD/CAM products with E4D Technologies and offer these products in North America under the brand names Planmeca PlanScan-E4D Technologies and PlanMill-E4D Technologies.  Henry Schein, Inc. will continue to be the exclusive distributor in the U.S., Canada, Australia, and New Zealand. In addition, Planmeca will expand distribution of the E4D system to more than 120 additional international markets under the Planmeca PlanScan and PlanMill brands. In certain other markets, the E4D brand will remain in use.

Planmeca’s investment in E4D Technologies offers us an opportunity to grow our company globally,” said Dr. Gary Severance, Chief Marketing Officer for E4D Technologies. “In addition, Planmeca has been a market leader in extra-oral digital imaging for many years, and we look forward to furthering the seamless integration of our CAD/CAM platform with the additional digital solutions offered by Planmeca. Our customers will benefit from the combination of these unique and innovative products and services.”

Under the new agreement, Planmeca joins the partnership of Henry Schein and Ivoclar Vivadent, who have been strategic equity partners in E4D Technologies since 2007, along with certain members of E4D Technologies’ senior management team.  

Old Years Night

As we all get ready to welcome in 2014 and all the possibilities it brings take a little bit of time to reflect on 2013. The wisdom gained from the past may just make it easier to make the future brighter.
So everyone have a safe Old Years Night or New Years Eve.

HAPPY NEW YEAR 2014

Monday, December 30, 2013

3M Continues to Focus on Its Digital Oral Care Platform

3M builds on recent success of the 3M™ True Definition Scanner and increases focus on its digital oral care technology platform

ST. PAUL, Minn.--(BUSINESS WIRE)-- In connection with Planmeca’s announcement today of its investment in E4D Technologies, 3M ESPE confirms it will continue to be a supplier of materials for the E4D Mill, including the 3M ESPE LavaTM Ultimate CAD/CAM Restorative block. 3M ESPE and E4D Technologies will continue to support the Trusted Connection between the 3M™ True Definition Scanner and the E4D Mill. Henry Schein will continue to offer the 3M™ True Definition Scanner and LavaTM Ultimate blocks for the E4D Mill.
3M will build on the recent success of the 3M™ True Definition Scanner and increase investment in its Digital Oral Care technology platform, both in the US and internationally.
3M ESPE is a dental product manufacturer that markets more than 2,000 dental products and services. 3M ESPE dental products are designed to help dental professionals improve their patients' oral health care. The 3M Digital Oral Care Department, part of the 3M ESPE Division, aims to accelerate and strengthen 3M’s efforts to lead the digital transformation that is occurring in oral care. 3M Health Care, one of 3M’s five Business Groups, provides world-class innovative products and services to help health care professionals improve the practice and delivery of patient care in medical, oral care, drug delivery and health information markets. For more information on the complete 3M ESPE line of dental products, visit the 3M ESPE website at http://www.3MESPE.com or call the 3M ESPE Technical Hotline at 1-800-634-2249. Products are available for purchase through authorized 3M ESPE distributors.
3M, ESPE and Lava are trademarks of 3M or 3M Deutschland GmbH. Used under license in Canada. © 3M 2013. All rights reserved.
About 3M
3M captures the spark of new ideas and transforms them into thousands of ingenious products. Our culture of creative collaboration inspires a never-ending stream of powerful technologies that make life better. 3M is the innovation company that never stops inventing. With $30 billion in sales, 3M employs 88,000 people worldwide and has operations in more than 70 countries. For more information, visit www.3M.com or follow @3MNews on Twitter.


Friday, December 27, 2013

Comparison of pulp response to mineral trioxide aggregate and a bioceramic paste in partial pulpotomy of sound human premolars: a randomized controlled trial

 

Abstract

Aim

This randomized clinical trial evaluated clinical sign/symptoms as well as histological pulp reactions in terms of inflammation and mineralized bridge formation after partial pulpotomy of sound human premolars and placement of a bioceramic Paste (iRoot BP) or tooth-colored ProRoot MTA as pulp covering biomaterials.

Methodology

Twenty four human sound premolars were randomly allocated into two experimental groups (n=12) either treated with iRoot BP or MTA subsequent to partial pulpotomy treatment. Six weeks after treatment, clinical sign/symptoms and radiographic changes were evaluated. The teeth were then extracted and examined histologically for inflammatory status of the pulp, formation of hard tissue bridge, and appearance of the bridge In terms of pulp inflammation and dentinal bridge formation the Mann–Whitney U and for clinical signs Chi square tests were used (α = 0.05).

Results

In terms of pulp inflammation, formation of hard tissue bridge and its appearance the differences between the two experimental groups were not significant. However, clinical sensitivity to cold was significantly less for teeth treated with MTA (p<0 .05="" a="" all="" and="" bridge="" cases="" either="" formed="" group="" had="" hard="" in="" necrosis.="" none="" of="" p="" pulpal="" specimens="" the="" tissue="">

Conclusion

When treating teeth with healthy pulps, the response to partial pulpotomy treatment with both MTA and iRoot BP was favourable. However,pulps covered with iRoot BP were more sensitive to cold stimuli.

Thursday, December 26, 2013

The effects of ageing on the biomechanical properties of root dentine and fracture

Available online 7 December 2013

Abstract

Objectives

Knowledge of the mechanical behaviour of root dentine can facilitate better understanding of spontaneous vertical root fracture (VRF), an age-related disease initiated mainly at the root apex. We tested the hypothesis that the biomechanical properties of root dentine change with ageing.

Methods

Sixteen human premolars were divided into “old” (17–30 years) and “young” (50–80 years) groups. The elastic modulus, nano-hardness, micro-hardness, elemental contents, tubular density/area of root dentine in cervical, middle and apical root regions were evaluated using atomic force microscopy-based nano-indentation, Knoop indentation, scanning electron microscopy and energy dispersive X-ray spectroscopy, respectively.

Results

The apical dentine showed a lower nano-hardness, a lower elastic modulus, a lower calcium content, a lower calcium-to-phosphorus ratio and a smaller tubular density/area than the cervical dentine in both age groups, whereas spatial differences in micro-hardness were observed only in old roots. Compared with young dentine, old dentine showed a greater hardness, a higher elastic modulus, a greater mineral content and a smaller tubular size in the cervical portion, whereas the age-induced changes in tubular density were insignificant. Finite element analysis revealed that due to its higher elastic modulus, old apical dentine has a higher stress level than young dentine.

Conclusions

The intrinsic material properties of root dentine have spatial variations, and they are altered by ageing. The higher stress level in old apical dentine may be one reason, if not the most important one, why spontaneous VRFs are more likely to occur in the elderly population.

Monday, December 23, 2013

Nonsurgical Treatment for Periodontal Disease May Not Be Enough for Patients with Diabetes



American Academy of Periodontology encourages dental professionals to continue to provide personalized care for patients with diabetes

CHICAGO – December 18, 2013 – A recent study published in the Journal of the American Medical Association (JAMA) found that nonsurgical treatment of periodontal disease does not improve glycemic control in patients with type 2 diabetes. Despite these results, the American Academy of Periodontology (AAP) continues to encourage clinicians to conduct annual comprehensive periodontal evaluations on patients and guide treatment and care based on provided outcomes.

Dr. Stuart J. Froum, DDS, President of the AAP and clinical professor and Director of Clinical Research in the Department of Periodontics and Implant Dentistry at New York University Dental Center, says the findings should not dismiss an association between periodontal disease and diabetes. “As a number of population studies suggest, there is indeed a relationship between diabetes and periodontal disease. While this study specifically focuses on basic nonsurgical periodontal care, some cases of periodontal disease require more intensive treatment. There is evidence that more intensive periodontal therapies can be effective in glycemic control.”

The study examined the impact of nonsurgical periodontal therapy on over 500 subjects with both type 2 diabetes and moderate to advanced chronic periodontitis. The subjects’ glycated hemoglobin (HbA1c) levels were assessed at three and six month intervals. Researchers found that compared to those who did not receive treatment, subjects that underwent nonsurgical periodontal therapy showed no difference in hemoglobin levels, suggesting no difference in glycemic control.

“It is important to note that the nonsurgical therapy employed in this study did not eradicate periodontal disease, which may be why researchers did not see an effect on glycemic control,” points out Dr. Froum. “A major indicator of periodontal disease - bleeding on probing - decreased only 19 percent, suggesting that the nonsurgical therapy was not successful in controlling moderate to advanced periodontal disease. The failure to eliminate periodontal disease may be why glycemic control was not impacted.”

Regardless, Dr. Froum is optimistic that this study may lead to a better understanding of the relationship between diabetes and periodontal disease. “I’m excited to see research that continues to explore the association between these two chronic, and highly prevalent, diseases. These findings are simply one piece of a complex puzzle and open the door for further investigation. “

According to the Centers for Disease Control and Prevention (CDC) and the AAP, nearly half of U.S. adults aged 30 or older have periodontal disease. As a result, the AAP recommends that all patients receive a comprehensive periodontal evaluation on an annual basis which includes a thorough assessment of periodontal health and any risk factors for disease. “Every patient requires an individualized treatment plan,” says Dr. Froum. “For patients with diabetes, this may include either nonsurgical periodontal care or more advanced treatment. Despite the lack of causal evidence, your patients should still be informed that maintaining periodontal health plays a larger role in systemic health.”

About the American Academy of Periodontology:
The American Academy of Periodontology (AAP) is the professional organization for periodontists – specialists in the prevention, diagnosis, and treatment of diseases affecting the gums and supporting structures of the teeth, and in the placement of dental implants. Periodontists are also dentistry’s experts in the treatment of oral inflammation. They receive three additional years of specialized training following dental school, and periodontics is one of the nine dental specialties recognized by the American Dental Association. The AAP has 8,300 members world-wide.


Friday, December 20, 2013

A Dental Gap in the Affordable Care Act

The Affordable Care Act mandated that insurers cover dental care for children. Indeed, it was one of the 10 essential health benefits meant to set the bar for adequate health insurance. But pediatric dental care is handled differently from coverage of other essential benefits on federal and state exchanges. These plans are often sold separately from medical insurance, and dental coverage for children is optional. People shopping on the exchanges are not required to buy it and do not receive financial support for buying it.
Now experts are warning that the flawed implementation of this benefit on the exchanges could leave millions of children without access to dental care. 

Thursday, December 19, 2013

Review of the PowerRocks

So I finally got some time to review the PowerRocks Magic Stick which I mentioned in the blog last month.

When I am attending a large dental meeting I need my phone to function from morning until late night. In many cases my iPhone has never measured up to the task, including the new iPhone 5S. On these days between meetings, text messaging and emails the battery gets very low around dinner time and I have to be very careful in conserving battery as I never know when I will need to make a call or get a message to someone. In the past I have used a large external battery which was a pain to lug around or a Mophie case for my previous iPhone. The Mophie case worked well but required me to change cases and this was a hassle at times to remove my Otterbox case form my iPhone. This is where the PowerRocks Magic Stick comes in. It is the size of a small flashlight and contains enough battery power to easily charge my iPhone and keep me safely using my device.

The PowerRocks is a USB battery pack containing 2800mAh of power. Easily enough power  to top off your phone or tablet. Since the device has a standard USB connector you can charge any phone, tablet or camera that has a USB cord for charging. It comes with a microUSB charging cable and small bag to put everything into. Just plug it into your standard USB wall charger and its good to go.

So no more changing cases when I need to go out of town. Its as simple as keeping the device with my other electronic goodies and slipping it into my conference bag or pocket. I don't worry about running out of power when carrying my PowerRocks Magic Stick battery as its just a simple plug and play for continued phone use.

So if you are considering an external battery charger consider the Power Rock Magic Stick.

Pros:
Small size and easy to carry
Can charge any USB Device (phones, tablets etc.)
Easy to share power with others
Quick topping off battery 
No need to carry a dedicated external battery

Cons:
Requires carrying the charging cable.

Wednesday, December 18, 2013

Fracture resistance and cuspal deflection of incompletely excavated teeth

Available online 12 December 2013

 

Abstract

Objectives

Incomplete excavation reduces the risk of pulpal complications, but doubts remain regarding the mechanical properties of incompletely excavated teeth. Remaining carious dentin is suspected to not sufficiently support the restoration and to reduce bond strengths between the tooth and the restoration, with effects possibly varying depending on the depth of the remaining caries lesion. This study investigated fracture resistance (FR) and cuspal deflection (CD) of premolars after leaving or removing demineralized dentin in vitro.

Methods

In 48 premolars, shallow and deep artificial lesions (depths [mean ± SD] of 64 ± 18 μm and 771 ± 176 μm) were created on pulpo-axial walls of standardized mesial-distal-occlusal cavities. Demineralized dentin was either removed or left before adhesively restoring the tooth (n = 12/group). Restored teeth were submitted to thermo-mechanical cycling. CD was subsequently measured at loads of 200 N and 400 N, and teeth submitted to occlusal-perpendicular loading until fracturing occurred.

Results

FR was not significantly different between teeth with or without remaining demineralized dentin regardless of the lesion depth (p > 0.30, t-test). Irrespective of the removal technique, teeth with deep lesions showed significantly decreased FR (p≤0.001). In contrast, CD was significantly increased in teeth with remaining demineralized dentin compared with completely excavated teeth (p≤0.05; Mann-Whitney-test).

Conclusions

Remaining demineralized dentin did not significantly decrease the fracture resistance of premolars in vitro. Effects of increased cuspal deflection on restoration margins should be assessed. This study showed no indication that incomplete excavation increases the risk of non-pulpal complications.
Clinical Significance: Incomplete caries removal seems suitable to treat especially deep lesions. Leaving demineralized dentin does not seem to affect the fracture resistance of incompletely excavated teeth regardless of the lesion depth.

Bond strength of overdenture locator posts cemented with seven luting agents.

J Contemp Dent Pract. 2013 Jul 1;14(4):675-80.

Abstract

Statement of the problem: Post retention is crucial factor in restoration survival. Posts are commonly failed due to loss of retention. It is unknown which luting agents would provide the maximum bond strength for Locator overdenture posts. Aim: The aim of this study was to evaluate the bond retentive strengths of Locator overdenture posts cemented with 7 luting agents. Materials and methods: One hundred and five single rooted human teeth were decoronated and randomly assigned to 7 groups (n = 15). Post spaces were prepared with Locator post drills to the depth of 6 mm. The Locator posts were cemented with Variolink II, RelyX ARC, Multilink N, RelyX Unicem, ParaCore, or MultiCore Flow resin luting agents. Zinc phosphate cement was served as control group. Specimens were stored in water at 37°C for 24 hours. Each specimen was loaded in tension in an Instron universal testing machine. The maximum force required to dislodge each Locator post was recorded. Means and standard deviations were calculated and data were statistically analyzed with one-way analysis of variance (ANOVA). Results: The highest mean bond strength value for Locator posts was recorded for MultiCore(®) Flow group (mean = 550.1 N), while the lowest mean value was for RelyX Unicem(™) resin cement group (mean = 216.8 N). A statistically significant difference in mean locator overdenture post bond strength was observed between the 7 cement types (p < 0.0001). ParaCore(™) and MultiCore(®) Flow groups had significantly higher bond strength than all other groups, but they were not differed from each other. Conclusion: Bond strength of Locator overdenture posts were influenced by the type of luting agents. MultiCore Flow and ParaCore resin cements offered the greatest retention. Clinical significance: The type of luting agents had a significant effect on the retention of Locator posts. The use of Core buildup resin cements as luting agent with Locator post demonstrated the greatest retention.

Tuesday, December 17, 2013

Shear bond strength of two adhesive materials to eroded enamel.

J Contemp Dent Pract. 2013 Jul 1;14(4):700-3.

Abstract

Aim: To evaluate the bond strength of one etch-and-rinse adhesive system and one resin-modified glass ionomer cement to sound and eroded enamel. Materials and methods: Forty-eight bovine incisors were embedded in acrylic resin and ground to obtain flat buccal enamel surfaces. Half of the specimens were submitted to erosion challenge with pH-cycling model (3x/cola drink for 7 days) to induce eroded enamel. After that, all specimens were randomly assigned according to adhesive material: etch-andrinse adhesive system (Adper Single Bond 2 - 3M ESPE, USA) or resin-modified glass ionomer cement (Vitro Fil LC - DFL, Brazil). The shear bond testing was performed after 24 hours water storage (0.5 mm/min). Shear bond strength means were analyzed by two-way ANOVA and Tukey post hoc tests (p < 0.05). Results: Adper Single Bond 2 showed the highest bond strength value to eroded enamel (p < 0.05), whereas no difference was observed in sound enamel compared with Vitro Fil LC (p > 0.05). Conclusion: Bond strength of etch-and-rinse adhesive system increases in eroded enamel, while no difference is verified to resin-modified glass ionomer cement. Clinical significance: Adhesive materials may be used in eroded enamel without jeopardizing the bonding quality; however it is preferable to use etch-and-rinse adhesive system.

Monday, December 16, 2013

Effect of energy drinks on the color stability of nanofilled composite resin.

J Contemp Dent Pract. 2013 Jul 1;14(4):704-11.

Abstract

Objective: To study the effect of three energy drinks on the color stability of nanofilled composite resins after different periods of aging time. Materials and methods: Composite resin disks, 6 mm diameter, 3 mm thickness were prepared from Filtec Z350 XT, Tetric EvoCeram, and Filtec Z250 XT. Specimens from each material were tested after aging with Red Bull, Bison and Power Horse energy drinks and distilled water as a control. Specimens were stored at 37°C in dark containers for 1, 7, 30 and 60 days. Color was assessed in the CIELAB using a colorimeter before and after each storage period. Color differences ΔE*ab and Δb* among specimens were measured. Mean values were statistically analyzed using one-way analysis of variance (ANOVA), with p < 0.05 as significance level. Results: The color change ΔE*ab and Δb* occurred by Red Bull, Bison and Power Horse energy drinks was significantly different for all tested materials at all four times p < 0.05 except in the Red Bull group. All specimens showed increase in color changes toward yellowness Δb* after a period of 1, 7, 30 and 60 days. The highest total color difference ΔE*ab was found in the Red Bull group after 60 days. Conclusion: Energy drinks used in this study had staining effect on the tested composite resin materials. The discoloration increased with aging time toward yellowness; however, it was not perceptible in all test groups after 60 days.

Friday, December 13, 2013

Carrier-based Root Canal Filling Materials: A Literature Review.

J Contemp Dent Pract. 2013 Jul 1;14(4):777-83.

Abstract

A review of the literature on the use of carrier based obturation materials focusing on Thermafil and Resilon based obturator (RealSeal 1) are presented in this article. The review addressed the history, apical leakage, coronal leakage, biocompatibility, sealing ability and clinical success of Thermafil and RealSeal 1. Based on the studies gathered, this review concluded that both treatment techniques (Thermafil and RealSeal 1) did not provide excellent apical sealing ability. More research should be done to try to overcome their main drawback, its sealing ability.

Thursday, December 12, 2013

Predicting compliance for mandible advancement splint therapy in 96 obstructive sleep apnea patients

Eur J Orthod 35 (6): 752-757. doi: 10.1093/ejo/cjs092

 

Abstract

SUMMARY The treatment of choice in obstructive sleep apnea (OSA) is continuous positive airway pressure (CPAP). Mandible advancement splint (MAS) offers an option for patients with mild or moderate OSA, who refuse or are unable to tolerate CPAP. The aim of the study was to find predictive factors in OSA for MAS therapy. The study group comprised 96 consecutive OSA patients who were sent for MAS therapy during 2008. Data were collected on the patients’ general and dental condition, diagnosis, and treatment for OSA. Panoramic and cephalometric radiographs were analysed. The treatment compliance rate and problems with the use of the MAS were recorded. This rate was 57% and the significant affecting factors were protrusion of the mandible with MAS during the adaptation to the appliance as well as shorter maxillary and mandible lengths. The compliance of the MAS therapy was best in patients with short maxilla and mandible, which should be taken into consideration when planning MAS therapy for OSA patients. Finally, a sleep study should be part of the follow-up in this patient population.

Wednesday, December 11, 2013

Casein phosphopeptide–amorphous calcium phosphate remineralization of primary teeth early enamel lesions

Reminerilizing toothpastes maybe better for kids then fluoride toothpaste? Interesting as I recommend these toothpastes strictly for high caries patients but maybe everyone could benefit? MJ
Available online 20 November 2013

 

Abstract

Early childhood caries (ECC) is a serious problem that progresses rapidly and often goes untreated. Current traumatic treatments may be replaced by safe and effective remineralization at very early stages.

Objective

The aim of this in vitro study was to evaluate the remineralization effects of casein phosphopeptide–amorphous calcium phosphate (CPP–ACP) paste on enamel lesions by assessing ultrastructure, nanomechanical properties, and compound and elemental analysis.

Methods

Enamel specimens from 6-year-old children were divided into groups: (1) native enamel; (2) water as negative control; (3) 500 ppm NaF as positive control; and (4–7) CPP–ACP paste for 4, 8, 12, and 24 h, as test groups. Ultrastructure and roughness were observed by atomic force microscopy (AFM); nanohardness and elastic modulus were measured by nanoindentation; compound and crystal size of enamel surface patterns were investigated by X-ray diffractometer (XRD). An electron microprobe (EPMA) was used for element analysis. Data were analyzed using one-way ANOVA.

Results

The CPP–ACP paste repaired the microstructure of enamel, including prism and interprism, through significantly increased hydroxyapatite crystal size (12.06 ± 0.21 nm) and Ca/P molar ratios (1.637 ± 0.096) as compared with NaF (8.56 ± 0.13 nm crystal size and 1.397 ± 0.086 Ca/P, p < 0.01). Both CPP–ACP and NaF decrease roughness, and increase the nanohardness and elastic modulus, with no significant differences between the materials.

Conclusions

The CPP–ACP paste is more suitable for children than NaF, due to advantages for remineralization. The AFM, nanoindentation, EPMA, and XRD are very helpful methods for further understanding of microscale and nanoscale remineralization mechanisms.

Tuesday, December 10, 2013

StarDental® Introduces the Newest Addition to its Classic 430 Handpiece Line: The 430-45


I got to hold these handpieces at the Greater NY Dental Meeting and they were light and well made at a very good price. MJ
 
The 430-45 Handpiece Features New 45° Angled Head for Superior Access
to Posterior Areas

Malvern, PA (December 1, 2013) – DentalEZ® Group, a supplier of innovative products and services for dental health professionals worldwide, is pleased to introduce the newest member of its classic 430 handpiece line, the 430-45. Available in two configurations, the 430 SWL® 45 and the 430 SW 45 are both equipped with a unique 45° angled head that provides unprecedented access to hard-to-reach posterior areas of the oral cavity. 

The 430-45 was specially designed to be the perfect handpiece for surgical procedures commonly performed by the general dentist such as removal of impacted molars, crown lengthenings, apicoectomies, and numerous other endodontic and periodontal practices. Along with the new 45° angle feature, the small head and optional fiber optic feature of the new 430-45 provide dental professionals with superior oral access and visibility.   

“The demand for specialized air-driven handpieces continues to grow as many general practitioners are experiencing seemingly routine cases that sometimes turn into more complex procedures,” remarked Rick Gross, StarDental Senior Product Manager. “Rather than investing in a multifaceted surgical system that can be extremely costly, we wanted to provide dentists with a more economical solution for these cases. With the 430-45, StarDental now offers the well-recognized 430 brand that dental professionals have grown to trust but with more specialized features.”

The 430-45 is equipped with specially designed side ports that effectively exhaust air away from the procedure area, therefore reducing the common risk of air embolism and protecting the integrity of the surgical site*. In addition, a pure stream of water is provided to keep the operatory site cool and clear. The 430-45 is available with or without solid glass rod fiber optics and accepts all standard and surgical length burs. 

“Our focus with the 430 line is to provide further choices and more variety for a wider array of individual preferences,” continued Gross. “We are very excited to offer the 430-45. It’s a great option for any dental professional who wants a multipurpose, flexible handpiece that can be used in a variety of situations.” 

As the #1 selling handpiece on the market**, each handpiece in the StarDental® 430 Series is an American Classic among dental professionals. Made with StarDental ceramic ball bearing turbines, the full family of the 430 Series includes: StarDental’s 430 SWL, featuring solid glass rod fiber optics, the 430 K®, 430 SW®, the 430 Satin, and the newest addition, the 430-45. Each is available in lubricated or StarDental’s traditional LubeFreewhich provides substantial cost and time savings. The small head and high-torque design of the 430 Series provides superior oral accessibility and visibility, and the high power enables fast and precise removal of tooth surface and amalgam. Its low noise level reduces the possibility of auditory damage and provides a more pleasant patient experience.  

For more information on the StarDental 430-45 and all DentalEZ products, please call 866-DTE-INFO or visit www.DentalEZ.com.   

*StarDental internal testing has shown that the 430 SWL® 45 and 430 SW 45 high-speed handpieces do not direct high-pressure air towards the cutting bur. The chip-air tube has been removed, eliminating drive air from being directed into the working area, thus reducing the risk of air embolism. 

**Document available upon request

About DentalEZ® Group

DentalEZ® Group is committed to advancing the practice of dentistry through innovative products and services. Encompassing six distinct product brands — StarDental®, DentalEZ®, CustomAir®, RAMVAC®, NevinLabs, and Columbia Dentoform® — DentalEZ® Group manufactures everything in the operatory, from handpieces to chairs to vacuum systems to dental simulation models, creating a complete line of products to elevate the health, comfort and efficiency of the dental operatory. For more information, please visit www.dentalez.com.

# # #





Monday, December 09, 2013

Henry Schein Signs Agreement To Invest In BioHorizons


Company Advances Strategy to Enhance Position in Dental Specialty Markets With Investment in Implant Manufacturer

MELVILLE, N.Y., Nov. 26, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners, announced today plans to make a strategic investment in dental implant manufacturer BioHorizons, Inc., advancing the Company's goal of expanding its position in the dental specialty market.
Henry Schein reached an agreement to acquire a 60% interest in BioHorizons, a U.S.-based manufacturer of advanced dental implants sold internationally. Under the agreement, BioHorizons, with revenue of approximately $115 million, will continue to operate as an independent company. Financial terms of the proposed transaction were not disclosed. The transaction with BioHorizons involves a two-step process: A recapitalization through which Henry Schein will lend approximately $145 million to BioHorizons to fund, among other uses, a distribution to shareholders, which will occur prior to closing, followed by the equity investment. Pending regulatory approval, Henry Schein expects to complete the transaction by the end of the year. 
The agreement with BioHorizons strengthens Henry Schein's position in a critical and growing market that also includes the company's investment in CAMLOG Biotechnologies AG, a leading manufacturer of implants in Europe. With these two investments, Henry Schein will have important positions in two of the largest implant markets – the U.S. and Germany – as well as a growing presence in the rest of the world. BioHorizons and CAMLOG, which will each operate independently, are strong brands with unique features and benefits that offer customers a broad range of treatment options. The investment in BioHorizons also strengthens Henry Schein's position and product portfolio in the biologics market, a critical adjunct to the implant market.  Henry Schein offers customers a wide array of the products and services associated with implant dentistry, thereby providing a complete solution for the benefit of the dental practice.
"Henry Schein's strategy includes advancing our position in dental specialty markets, an integral part of which is to support those practitioners who perform oral surgery involving implants," said Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein. "Implant dentistry is a critical element of the profession's transition to digital dentistry. More and more abutments for implants are being digitally designed and fabricated, which increase patient comfort and esthetics and reduce patient visits. Customer demand for implants and the associated materials are expected to increase as digital processes are adopted and the dental experience for the patient is enhanced."
The value of the global implant market is expected to reach approximately $4.2 billion in 2016, up from approximately $3 billion in 2012. In the U.S. and Canada, the market is expected to reach $1.5 billion in 2016, up from approximately $1 billion in 2012.
Based in Birmingham, Alabama, BioHorizons employs approximately 325 people and markets its products in 85 markets.  Its revenue has been growing on average by more than 10 percent annually, and more than half of that revenue is derived in the U.S.  Founded in 1995, the company offers a broad spectrum of innovative products, including implants featuring its proprietary Laser-Lok® microchannel surface technology, designed to minimize bone loss and maximize esthetics.
"On behalf of the shareholders and management of BioHorizons, we are delighted with this partnership, which combines BioHorizons' record of global growth and clinical excellence in the implant dentistry field with Henry Schein's strengths worldwide," said Mortimer Berkowitz III, Chairman of BioHorizons. "Having known the Henry Schein management team for some years, we look forward to working closely with them to build the business into a global leadership position by delivering outstanding patient results through differentiated products."
BioHorizons benefits from a long-serving management team. The company will continue to be led by its President and CEO, Steve Boggan, who has held that position since 1999; Todd Strong, Executive Vice President and Chief Operating Officer, who joined BioHorizons at its founding in 1995; and David Wall, Executive Vice President and Chief Financial Officer. BioHorizons will be a part of Henry Schein's Global Dental Surgical Group, and its revenue will be reported as part of the Company's Global Dental Group.
"We believe our partnership with Henry Schein will further enhance our growth prospects in the implant and biologics market," said Mr. Boggan. "The strength of Henry Schein and its deep relationships in the marketplace create an ideal combination. We are looking forward to advancing the goals of both organizations, and are very pleased to be part of Team Schein."
2014 Guidance
Henry Schein expects the BioHorizons transaction to be dilutive to earnings per share in 2014 by $0.03 to $0.05, and accretive to earnings per share in 2015 by $0.03 to $0.04. The 2014 dilution is primarily due to a one-time inventory revaluation as required under U.S. GAAP accounting rules for business combinations. Together with the previously announced definitive agreement to acquire 80% of Poland's Medivet S.A., the Company has revised its 2014 financial guidance, as follows:
  • For 2014, the Company now expects diluted EPS attributable to Henry Schein, Inc. to be $5.32 to $5.42, which represents growth of 9% to 11% compared with the midpoint of the 2013 guidance range.
  • Guidance for 2014 diluted EPS attributable to Henry Schein, Inc. is for current continuing operations as well as completed or previously announced acquisitions, and does not include the impact of potential future acquisitions, if any.
About BioHorizons
BioHorizons is a leader in advanced dental implant technologies and tissue regeneration products in the dental implant industry. The company, based in Birmingham, Alabama, offers a broad spectrum of products for the replacement of missing teeth including dental implants, restorative and laboratory components, soft and hard tissue biologic products, and surgical planning software.  BioHorizons' unique dental implant designs are recognized for intuitive design, excellent primary stability, and high-end, esthetic outcomes through the use of BioHorizons' proprietary Laser-Lok® microchannel surface technology. With 25 years of research and 30 published studies, Laser-Lok has been shown to uniquely achieve both bone and soft tissue attachment for long-term tissue maintenance. The company has six international subsidiaries and more than 50 distributors around the world.   For more information, visit www.biohorizons.com.
About Henry Schein, Inc.
Henry Schein, Inc. is the world's largest provider of health care products and services to office-based dental, animal health and medical practitioners. The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites. A Fortune 500® Company and a member  of the NASDAQ 100® Index, Henry Schein employs nearly 16,000 Team Schein Members and serves more than 775,000 customers.
The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care. Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.
Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries. The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17% since Henry Schein became a public company in 1995. For more information, visit the Henry Schein Web site at www.henryschein.com.

Friday, December 06, 2013

DEXIS Previews Its Upcoming Imaging Software For Mac® In The Big Apple


DEXIS, an industry leader and the manufacturer of the highly awarded DEXIS® Digital X-ray system, is now in the process of completing its development for the Mac platform and will soon be expanding its Imaging Suite of products to natively support Apple® hardware and the OS X® operating system (10.8 or newer).

Hatfield, PA/New York, NY (December 1, 2013) DEXIS is pleased to preview its outstanding Mac product at an exclusive press event during the Greater New York Dental Meeting. DEXIS Mac™ is an innovative dental imaging solution that offers dentists a unified experience across Mac and iOS products. Once released, the native OS X software will provide clinicians with a highly efficient digital imaging workflow and seamless integration with leading Mac-based practice management programs Viive™ and MacPractice®.

Dentists who have been looking for a native dental imaging software for the Mac will soon be able to enjoy the combination of this exciting new DEXIS release with the established user experience of Apple products. The DEXIS software will provide an intuitive user interface and advanced functionality that Mac users expect – combined with tried-and-true DEXIS image management and enhancement tools.

A tight integration between DEXIS Mac, the award-winning DEXIS go® app for patient communication, and the just released DEXIS photo™ app for extra-oral image acquisition is in the making as well and will add even more effectiveness for the Mac-based dentist. The apps collectively operate on iPad®, iPhone® and iPod touch®. Recognizing the fact that both patient education and case presentation is immensely important, DEXIS Mac will support both Mac OS X full-screen mode and AirPlay® mode for presenting on larger displays.

DEXIS Mac is scheduled to be formally introduced in Q2 of 2014.

About DEXIS Mac
DEXIS Mac is under development and is pending Regulatory assessment and clearance. This announcement is for notification only. No orders can be accepted until appropriate Regulatory filing, registrations, or licenses are either cleared or updated.

About DEXIS
DEXIS is an industry leader in developing high quality digital imaging solutions for the dental community. In 1997, DEXIS introduced digital radiography on laptop computers — making it the first truly portable and affordable digital X-ray system. In 2001, DEXIS became the first intra-oral digital radiography system to be accepted by the American Dental Association into the highly prestigious ADA Seal Program. Today, DEXIS is the most highly awarded intra-oral digital X-ray system with numerous awards from dental researchers and well-respected dental publications. For more information on the DEXIS® Imaging Suite of software products and the DEXIS® Platinum Sensor, visit www.dexis.com.